At the heart of healthcare investing is a deep appreciation for science. David Anderson, General Partner at Ampersand, combines his scientific training with a deep understanding of the business landscape to drive growth in the healthcare sector. With a unique background as a scientist, David emphasizes that engaging with founder-led companies is about more than just numbers—it's about the technology and its impact on patient care.
At Ampersand, a Boston-based private equity firm with $3 billion in assets under management, the focus is on growth-oriented investments within the life sciences ecosystem. By prioritizing relationships with entrepreneurs, Ampersand aims to be the first institutional investor, helping businesses navigate challenges and unlock their full potential.
Through collaboration and open dialogue, Ampersand not only helps founders navigate the complexities of the healthcare market, but also strengthens their capacity to innovate and lead.
